Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
stability. This position will closely collaborate with colleagues across PharmSci as well as with partners in Medicinal Chemistry, Pharmacokinetics & Drug Metabolism, and Clinical Pharmacology. You will be
-
pharmaceutical science, chemistry, engineering (chemical or mechanical), biology, physics, or related field with 3+ years of experience or a Master's Degree (MA/MS) in the same fields. Excellent written and oral
-
ROLE SUMMARY At Pfizer oncology we deliver breakthroughs that change patients' lives with the mission to outdo cancer. The ADC (Antibody-Drug-Conjugate) chemistry team plays a vital role in this
-
small molecule NMR and Mass Spectrometry to drive the design and synthesis of Pfizer's medicinal chemistry portfolio. You will work closely with medicinal chemistry to elucidate compound structures and
-
technical expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies
-
ROLE SUMMARY Our Internal Medicine (IM) Medicinal Chemistry Group delivers scientific excellence in the small-molecule medicinal chemistry portfolio aligned to the IM Research Unit (IM RU). You will
-
ROLE SUMMARY Our Internal Medicine (IM) Medicinal Chemistry Group delivers scientific excellence in the small-molecule medicinal chemistry portfolio aligned to the IM Research Unit (IM RU). You will
-
ROLE SUMMARY Our Internal Medicine (IM) Medicinal Chemistry Group delivers scientific excellence in the small-molecule medicinal chemistry portfolio aligned to the IM Research Unit (IM RU). You will
-
for support and expertise. The role also involves assisting in the resolution of technical challenges related to particle analysis. Qualifications Must-Have Ph.D. in Analytical Chemistry or a related field with
-
scientists engage in all facets of development from small scale synthesis in support of medicinal chemistry programs, to the development of the commercial synthetic route. CRD scientists partner with